Work

Carfilzomib-Lenalidomide-Dexamethasone Versus Bortezomib-Lenalidomide-Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma: Results from the Prospective, Longitudinal, Observational Commpass Study

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-112289

Authors: Ola Landgren, David S Siegel, Daniel Auclair, Ajai Chari, Michael Boedigheimer, Tim Welliver, Khalid Mezzi, Karim Iskander, Andrzej Jakubowiak

Institutions: Memorial Sloan Kettering Cancer Center, Hackensack University Medical Center, Multiple Myeloma Research Foundation, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Amgen (United States), University of Chicago

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2899385972

Cites:

Cited by: 9

Related to: 10